Ads
related to: abbvie upadacitinib atopic dermatitis- RINVOQ® Complete
Get Access To Prescription Savings
And Insurance Coverage Info.
- Set Treatment Goals
Talk With Your Doctor About
Setting Goals That Work For You.
- RINVOQ® Complete
Search results
AbbVie's (ABBV) Rinvoq Meets Key Goal in Phase II Vitiligo Study
Zacks via Yahoo Finance· 7 months agoAbbVie ABBV announced positive results from its mid-stage study evaluating Rinvoq (upadacitinib) in...
Here's How Much You'd Have If You Invested $1000 in AbbVie a Decade Ago
Zacks via Yahoo Finance· 5 months agoHow much a stock's price changes over time is important for most investors, since price performance...
AbbVie's (ABBV) Rinvoq Gets CHMP Nod for New Indication
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV announced that the European Medicines Agency’s Committee for Medicinal Products for...
AbbVie (ABBV) Files NDA for Parkinson's Disease Candidate
Zacks via Yahoo Finance· 2 years agoAbbVie Inc. ABBV submitted a new drug application (“NDA”) for ABBV-951 (foscarbidopa/foslevodopa)...
AbbVie (ABBV) Outperforms Industry This Year So Far: Here's Why
Zacks via Yahoo Finance· 2 years agoAbbVie (ABBV) has several new drugs with the potential to drive revenues once Humira loses U.S....
AbbVie's (ABBV) Rinvoq Gets FDA Nod to Treat Crohn's Disease
Zacks via Yahoo Finance· 12 months agoAbbVie (ABBV) announces the seventh FDA approval of its JAK inhibitor, Rinvoq, for the treatment of...
AbbVie's (ABBV) Rinvoq Meets Crohn's Disease Study Goals
Zacks via Yahoo Finance· 2 years agoAbbVie's (ABBV) Rinvoq achieves statistical significance with its co-primary endpoints of clinical...
Can AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales?
Zacks via Yahoo Finance· 2 years agoAbbVie's (ABBV) new drugs, Skyrizi and Rinvoq, are faring well, bolstered by approval in new...
The Zacks Analyst Blog Highlights Sanofi, Regeneron, AbbVie, Roche and Eli Lilly
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – March 27, 2023 – Zacks.com announces the list of stocks featured...
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III
Zacks via Yahoo Finance· 9 months agoThis week, AstraZeneca AZN, Sanofi SNY and AbbVie ABBV and Roche announced second-quarter earnings....
Ads
related to: abbvie upadacitinib atopic dermatitis
